WHO strongly recommends antiviral drug for patients with non-severe covid-19: A combination of nirmatrelvir and ritonavir is strongly recommended for patients at highest risk of...
WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission: The antiviral drug molnupiravir is conditionally recommended for patients with...
Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls with translating drugs such as...
Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time In just six months, the world’s largest randomized...